OTC Link · Healthcare · Medical Devices
PETVIVO HOLDINGS INC
Revenue surged **562% YoY** to $255K, but massive -1131% margins signal unsustainable growth. Executive salary cuts underscore cash burn concerns at this micro-cap medical device play.
AI-generated summary — powered by BigEarnings.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-29 | Q4 2026 | — | -0.11 | — | $254,715 | — | +0.00% | -9.09% | — |
| 2026-02-17 | Q3 2026 | — | -0.07 | — | $286,108 | — | +0.00% | +4.48% | +17.91% |
| 2025-11-14 |
| Q2 2026 |
| — |
| -0.11 |
| — |
| $303,284 |
| — |
| — |
| — |
| — |
| 2025-08-14 | Q1 2026 | — | -0.09 | — | $297,500 | — | +0.00% | +6.15% | +14.75% |
| 2025-02-14 | Q3 2025 | — | -0.09 | — | $583,313 | — | -18.86% | -20.22% | -25.63% |
| 2024-11-14 | Q2 2025 | — | -0.11 | — | $200,720 | — | +3.11% | -2.87% | -16.21% |
| 2024-08-14 | Q1 2025 | — | -0.11 | — | $123,751 | — | -8.56% | -11.05% | +6.21% |
| 2024-06-28 | Q4 2024 | — | -0.14 | — | $48,266 | — | -32.50% | -11.54% | +30.75% |
Showing last 8 quarters.